NSS IB-STIM
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $22,500 | 3 | 0 |
| 2021 | $117,747 | 26 | 9 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $132,275 | 20 | 94.3% |
| Consulting Fee | $6,000 | 6 | 4.3% |
| Food and Beverage | $1,972 | 3 | 1.4% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Neuromodulation with Percutaneous Electrical Nerve Field Stimulation for Adults with Irritable Bowel Syndrome: A Randomized, Double-Blind, Sham-Controlled Pilot Study | Innovative Health Solutions, Inc. | $24,300 | 0 |
| Prospective Study on the effect of Auricular Percutaneous Electrical Nerve Field Stimulation (PENFS) in patients with Post-Concussion Syndrome (PCS) | NeurAxis, Inc. | $22,500 | 0 |
| Prospective Study on the effect of Auricular Percutaneous Electrical Nerve Field Stimulation (PENFS) in patients with Post-Concussion Syndrome (PCS) | Innovative Health Solutions, Inc. | $20,475 | 0 |
| Defining Adolescent Nausea through Brain-Gut Physiology and Neurostimulation Response | Innovative Health Solutions, Inc. | $19,000 | 0 |
| Hypermobile Ehlers-Danlos Syndrome: Efficacy of Non-invasive Vagal nerve Stimulation and Effects on Brain-Gut Physiology | Innovative Health Solutions, Inc. | $18,000 | 0 |
| Efficacy of Auricular Neurostimulation for Children and Adults with Cyclic Vomiting Syndrome: a Pilot Stud | Innovative Health Solutions, Inc. | $10,000 | 0 |
| Effect of percutaneous electrical field stimulation (PENFS) on vagal nerve compound actions, parasympathetic and sympathetic vagal nerve activity, and gastric myoelectrical activity in human subjects. | Innovative Health Solutions, Inc. | $9,000 | 0 |
| Non-pharmacologic Management of Postural Orthostatic Tachycardia using Percutaneous Vagus Nerve Stimulation | Innovative Health Solutions, Inc. | $9,000 | 0 |
Top Doctors Receiving Payments for NSS IB-STIM
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Milwauke, WI | $132,275 | 20 |
| , MD | Pediatric Gastroenterology | Boston, MA | $1,000 | 1 |
| , MD | Pediatric Gastroenterology | Miami, FL | $1,000 | 1 |
| , MD | Pediatric Gastroenterology | Boston, MA | $1,000 | 1 |
| , MD | Pediatric Gastroenterology | Columbus, OH | $1,000 | 1 |
| , M.D | Pediatric Gastroenterology | Cincinnati, OH | $1,000 | 1 |
| , MD | Pediatric Gastroenterology | New Haven, CT | $1,000 | 1 |
| , MD | Pediatrics | Charlotte, NC | $855.96 | 1 |
| , MD | Pediatrics | Charlotte, NC | $855.96 | 1 |
| , D.O | Pediatrics | Miami, FL | $259.70 | 1 |
Manufacturing Companies
- Innovative Health Solutions, Inc. $117,747
- NeurAxis, Inc. $22,500
Product Information
- Type Device
- Total Payments $140,247
- Total Doctors 9
- Transactions 29
About NSS IB-STIM
NSS IB-STIM is a device associated with $140,247 in payments to 9 healthcare providers, recorded across 29 transactions in the CMS Open Payments database. The primary manufacturer is Innovative Health Solutions, Inc..
Payment data is available from 2021 to 2022. In 2022, $22,500 was paid across 3 transactions to 0 doctors.
The most common payment nature for NSS IB-STIM is "Unspecified" ($132,275, 94.3% of total).
NSS IB-STIM is associated with 8 research studies, including "Neuromodulation with Percutaneous Electrical Nerve Field Stimulation for Adults with Irritable Bowel Syndrome: A Randomized, Double-Blind, Sham-Controlled Pilot Study" ($24,300).